“…RA has been a focus for decades, its structure (Steinmetz and Lin, 2009;Upreti et al, 2012), pharmacokinetic (Wheeler et al, 2008), stability properties WÖlwer-Rieck et al, 2010), clinical safety (Hsieh et al, 2003), and toxicologies, including chronic toxicity Nikiforov and Eapen, 2008), genotoxicity (Williams and Burdock, 2009), carcinogenicity (Toyoda et al, 1997;Xili et al, 1992), reproductive and developmental toxicity had been fully studied. In addition, some beneficial functions of RA, including nontoxicological effects, antioxidant, antihypertensive, anti-Inflammatory and immunomodulatory activities, and antihyperglycemic activities had also been proved (Boonkaewwan et al, 2006;Chan et al, 2000;Gregersen et al, 2004;Jeppesen et al, 2002;Lee et al, 2001;Tadhani et al, 2007).…”